Literature DB >> 20613764

The pattern of natural selection in somatic cancer mutations of human mtDNA.

Pete Stafford1, Estella B Chen-Quin.   

Abstract

Tumors frequently contain somatic mutations in the mitochondrial DNA (mtDNA). Whether these mutations have a causal function or are merely an effect is still unclear. As tumor formation is a type of somatic evolution, we examine the cancer mutation pattern for consistency with random forces or selection. We also compare the tumor mutation pattern to that observed in the population to gain insight on the mutation process in cancer. Among germline mtDNAs, all genes show strong deficiency in missense changes, reflecting negative selection during human history. In somatic cancer sequences, mtDNA genes show relaxed negative selection relative to germline, or mutation consistent with neutrality. NADH dehydrogenase subunit 3, cytochrome c oxidase subunit 3 and NADH dehydrogenase subunit 4 L in particular show cancer missense mutation rates 9-18 times that of germline. Bootstrap analysis shows cytochrome B to have cancer changes in positions of unusually high conservation, suggesting that tumors select for mutations in residues of high functionality. Strong negative selection was detected in mitochondrially encoded cytochrome c oxidase 1 (MTCO1), suggesting that tumor cells are dependent upon MTCO1 function. Common population polymorphisms were also frequently reported among somatic tumor mutations. The implication of these 'somatic polymorphisms' in tumor growth is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20613764     DOI: 10.1038/jhg.2010.76

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  8 in total

Review 1.  Evolution of the couple cytochrome c and cytochrome c oxidase in primates.

Authors:  Denis Pierron; Derek E Wildman; Maik Hüttemann; Thierry Letellier; Lawrence I Grossman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.

Authors:  Jennifer Permuth-Wey; Y Ann Chen; Ya-Yu Tsai; Zhihua Chen; Xiaotao Qu; Johnathan M Lancaster; Heather Stockwell; Getachew Dagne; Edwin Iversen; Harvey Risch; Jill Barnholtz-Sloan; Julie M Cunningham; Robert A Vierkant; Brooke L Fridley; Rebecca Sutphen; John McLaughlin; Steven A Narod; Ellen L Goode; Joellen M Schildkraut; David Fenstermacher; Catherine M Phelan; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-29       Impact factor: 4.254

3.  Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.

Authors:  Anita Kloss-Brandstätter; Georg Schäfer; Gertraud Erhart; Alexander Hüttenhofer; Stefan Coassin; Christof Seifarth; Monika Summerer; Jasmin Bektic; Helmut Klocker; Florian Kronenberg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

4.  Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.

Authors:  Edoardo Errichiello; Antonella Balsamo; Marianna Cerni; Tiziana Venesio
Journal:  J Mol Med (Berl)       Date:  2015-07-03       Impact factor: 4.599

Review 5.  Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.

Authors:  Luísa Pereira; Pedro Soares; Valdemar Máximo; David C Samuels
Journal:  BMC Cancer       Date:  2012-02-02       Impact factor: 4.430

Review 6.  The Landscape of mtDNA Modifications in Cancer: A Tale of Two Cities.

Authors:  Kate L Hertweck; Santanu Dasgupta
Journal:  Front Oncol       Date:  2017-11-02       Impact factor: 6.244

7.  Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma.

Authors:  Andy G X Zeng; Andy C Y Leung; Angela R Brooks-Wilson
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

8.  Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in Tumors.

Authors:  Carlos Jhovani Pérez-Amado; Hugo Tovar; Laura Gómez-Romero; Fredy Omar Beltrán-Anaya; Verónica Bautista-Piña; Carlos Dominguez-Reyes; Felipe Villegas-Carlos; Alberto Tenorio-Torres; Luis Alberto Alfaro-Ruíz; Alfredo Hidalgo-Miranda; Silvia Jiménez-Morales
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.